Puma Biotechnology, Inc.
(NASDAQ : PBYI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.33%159.750.7%$1251.42m
LLYEli Lilly & Co. -1.66%327.411.1%$1087.67m
ABBVAbbVie, Inc. -1.17%138.651.9%$850.49m
PFEPfizer Inc. -2.18%42.150.9%$785.74m
BMYBristol-Myers Squibb Co. -0.54%69.861.0%$747.73m
MRKMerck & Co., Inc. -0.14%87.320.7%$696.69m
AZNAstraZeneca Plc 1.26%55.601.0%$391.04m
ALNYAlnylam Pharmaceuticals, Inc. -2.13%198.068.2%$220.04m
GSKGSK Plc 0.45%30.140.3%$209.49m
NVSNovartis AG -0.54%75.630.2%$199.82m
HZNPHorizon Therapeutics Plc -3.51%65.515.4%$182.09m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
IDXXIDEXX Laboratories, Inc. -3.56%333.723.9%$177.78m
SRPTSarepta Therapeutics, Inc. -2.42%112.0412.4%$138.30m
AKROAkero Therapeutics, Inc. -1.48%38.680.0%$132.19m

Company Profile

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.